Synaptosomal‐Associated Protein 25 kDA (SNAP‐25) Levels in Cerebrospinal Fluid: Implications for Alzheimer's Disease Diagnosis and Monitoring
Synapse · 2025-03 · 79 (2)
DOI: 10.1002/syn.70010 ↗At a glance
Evaluationsstudie in Synapse, published online on 2025-02-06. Written by Sofia Hjorth Wolner and 12 co-authors. Institution: Danish Dementia Research Centre, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Major MEDLINE topics: Synaptosomal-Associated Protein 25, Alzheimer Disease, Dementia. Cited 11 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Swedish Alzheimer Foundation, Alzheimer's Drug Discovery Foundation, Familjen Erling-Perssons Stiftelse.
Topics: Demenz
Abstract (original language)
Synaptic degeneration has been linked to cognitive decline. The presynaptic protein, synaptosomal‐associated protein 25 kDA (SNAP‐25), is crucial for synaptic transmission and has been suggested as a biomarker in Alzheimer's disease (AD). In the current study, we investigated the ability of SNAP‐25 to differentiate between heterogenous dementia etiologies and whether SNAP‐25 could be a staging marker in AD. SNAP‐25 in the cerebrospinal fluid (CSF) from a retrospective ( n = 187) and a prospective ( n = 134) cohort was investigated with immunoprecipitation mass spectrometry (IP‐MS) and single‐molecule array (Simoa), respectively. Both cohorts consisted of healthy controls (HC) and patients with cognitive decline of different etiologies. CSF SNAP‐25 concentration was higher in AD and non‐neurodegenerative diseases (i.e., vascular dementia) compared with controls but did not differ between AD and non‐AD neurodegenerative diseases. We found a trend toward an association between SNAP‐25 and disease burden when comparing HC, mild cognitive impairment due to AD, and AD. CSF SNAP‐25 concentrations were strongly associated with CSF phosphorylated tau (p‐tau) concentrations, thus strengthening the link between synaptic dysfunction and tau pathophysiology in AD. Our initial findings suggest that SNAP‐25 may be a potential biomarker for differentiating AD from dementia due to other etiologies. However, due to the significant association between SNAP‐25 and p‐tau proteins, the clinical utility of SNAP‐25 as a diagnostic biomarker for AD may be limited, while SNAP‐25 may be useful for monitoring disease progression or treatment response.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Danish Dementia Research Centre, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Regional Dementia Research Centre, Department of Neurology, Zealand University Hospital, Roskilde, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
- Institute of Psychiatry, Psychology and Neuroscience Maurice Wohl Institute Clinical Neuroscience Institute, King's College London, London, UK.
- NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK.
ORCID profiles: Anja Hviid Simonsen
Funding
- Swedish Alzheimer Foundation
- Alzheimer's Drug Discovery Foundation
- Familjen Erling-Perssons Stiftelse
- UK Dementia Research Institute
- NIA NIH HHS
- European Union Joint Programme - Neurodegenerative Disease Research
- Bluefield Project
- Absalon Foundation
Cite
APA
Wolner, S. H., Gleerup, H. S., Musaeus, C. S., Høgh, P., Ashton, N. J., Brinkmalm, A., Nilsson, J., Grötschel, L., Zetterberg, H., Blennow, K., Hasselbalch, S. G., Walls, A. B., & Simonsen, A. H. (2025). Synaptosomal‐Associated Protein 25 kDA (SNAP‐25) Levels in Cerebrospinal Fluid: Implications for Alzheimer's Disease Diagnosis and Monitoring. Synapse, 79(2). https://doi.org/10.1002/syn.70010
Vancouver
Wolner SH, Gleerup HS, Musaeus CS, Høgh P, Ashton NJ, Brinkmalm A, et al. Synaptosomal‐Associated Protein 25 kDA (SNAP‐25) Levels in Cerebrospinal Fluid: Implications for Alzheimer's Disease Diagnosis and Monitoring. Synapse. 2025;79(2). doi:10.1002/syn.70010
BibTeX
@article{Wolner2025,
author = {Wolner, Sofia Hjorth and Gleerup, Helena Sophia and Musaeus, Christian Sandøe and Høgh, Peter and Ashton, Nicholas J and Brinkmalm, Ann and Nilsson, Johanna and Grötschel, Lana and Zetterberg, Henrik and Blennow, Kaj and Hasselbalch, Steen Gregers and Walls, Anne Byriel and Simonsen, Anja Hviid},
title = {Synaptosomal‐Associated Protein 25 kDA (SNAP‐25) Levels in Cerebrospinal Fluid: Implications for Alzheimer's Disease Diagnosis and Monitoring},
journal = {Synapse},
year = {2025},
volume = {79},
number = {2},
doi = {10.1002/syn.70010}
}
EUVIMED